Turkesterone and Ecdysteroids: Separating Hype from Evidence

What Ecdysteroids Actually Are

Ecdysteroids are hormones that control molting and development in insects and crustaceans. When an insect sheds its exoskeleton, ecdysteroids are the signal that triggers it. Plants make their own versions, called phytoecdysteroids, and the leading theory is that they evolved as a chemical defense: an insect that eats a plant loaded with ecdysteroids gets a scrambled developmental signal and stops being a problem.

The two that matter for this discussion are ecdysterone (also written 20-hydroxyecdysone, 20E, or beta-ecdysterone) and turkesterone. They are structurally close. Turkesterone carries an additional hydroxyl group at the 11-alpha position, which is the entire chemical difference the marketing was built on. Ecdysterone is by far the more abundant and more studied of the two.

Commercially, they come from three plants: Ajuga turkestanica (the primary turkesterone source, native to Uzbekistan), Rhaponticum carthamoides (maral root, a Russian sports-nutrition staple since the Soviet era), and Cyanotis vaga or Cyanotis arachnoidea, which is the cheap industrial source. They also occur in ordinary food. Spinach, quinoa, and asparagus all contain measurable ecdysterone, which becomes relevant later when we get to anti-doping policy.

One point worth fixing early, because most of the confusion downstream comes from missing it. Ecdysteroids are steroids in the chemical sense, meaning they share the four-ring carbon skeleton that defines the class. Cholesterol is a steroid. Vitamin D is a steroid. Being a steroid is a statement about shape, not about what a molecule does in a human body. Ecdysteroids do not bind the androgen receptor, which is the receptor that makes testosterone and its derivatives work.

Where the Hype Came From

The turkesterone boom is a case study in how one paper becomes a product category.

For decades, phytoecdysteroids sat in obscure Soviet and Uzbek pharmacology journals. Researchers including V.N. Syrov published rodent work through the 1970s to the 2000s reporting that turkesterone and related compounds increased protein synthesis in rat liver and muscle tissue, with some papers describing anabolic activity in the same range as methandienone (Dianabol) but without androgenic effects. Those papers are the origin of every "as anabolic as Dianabol, no side effects" claim you have ever seen in a turkesterone ad. They involved rodents, frequently used injection rather than oral dosing, and measured tissue protein synthesis rather than muscle growth in a training human.

Nothing much happened with that literature in Western sports nutrition until 2019, when a research team from the German Sport University Cologne and the Free University of Berlin published a ten-week human trial on ecdysterone in Archives of Toxicology (Isenmann et al., 2019). The results looked dramatic, and the authors recommended that ecdysterone be added to the WADA Prohibited List under class S1.2, "other anabolic agents."

That recommendation was the hook. A supplement that scientists want banned for being too effective is a marketing dream, and by 2021 the fitness content ecosystem had run with it. YouTube and TikTok did the rest. Somewhere in that cycle the marketed molecule shifted from ecdysterone, which the study actually tested, to turkesterone, which it did not. Turkesterone was rarer, sounded more exotic, commanded a higher price, and critically had no null studies attached to its name yet.

The study that launched turkesterone did not test turkesterone. It tested ecdysterone, at doses the same paper's own chemical analysis showed the capsules did not contain.

The Proposed Mechanism

The leading hypothesis is that ecdysteroids act through estrogen receptor beta (ERβ) in skeletal muscle, which sits upstream of the Akt/mTOR pathway that controls muscle protein synthesis. Cell culture work supports parts of this. In C2C12 mouse myotubes and in human primary myotubes, phytoecdysteroids have increased protein synthesis by roughly 20% in some experiments, and blocking ERβ blunts the effect.

Notice what is attractive about this story. It gives you a growth signal that bypasses the androgen receptor entirely, which would explain both the anabolic claim and the absence of the usual androgenic problems: no testosterone suppression, no acne, no hair loss, no need for post-cycle anything. That is a genuinely interesting pharmacological idea, and it is why serious researchers keep looking at this class.

The problem is what happens between the petri dish and the person. A compound that raises protein synthesis 20% in cultured muscle cells is being applied directly to those cells at a known concentration. To reproduce that in a human, the molecule has to survive the gut, survive first-pass liver metabolism, reach skeletal muscle at a meaningful concentration, and stay there long enough to matter. Ecdysteroids fail badly at several of those steps, which we get to shortly.

It is also worth noting that the animal literature is not unanimous. Lawrence et al. (2021), publishing in the International Journal of Environmental Research and Public Health, tested phytoecdysteroids in sedentary aging mice and found no anabolic effects in skeletal muscle. The title is about as blunt as academic titles get: "Phytoecdysteroids Do Not Have Anabolic Effects in Skeletal Muscle in Sedentary Aging Mice."

Every Human Trial, Scored

This is the section that matters. There are not many human trials on ecdysteroids for muscle and performance, which makes it feasible to list all of them rather than cherry-pick.

Six controlled human trials. One positive. Five null. And the positive one is on ecdysterone, not turkesterone, and carries a specific measurement problem that we will get to in the next section.

Look at the two trials that tested turkesterone as a training aid. Antonio et al. (2024) gave 31 active adults 500 mg per day of an Ajuga turkestanica extract for four weeks against a rice flour placebo and reported no between-group differences in body mass, lean body mass, fat mass, or body fat percentage. The paper's subtitle tells you how the authors felt about the marketing: "It's Not Deca." The 2025 trial published in the Journal of the International Society of Sports Nutrition used a commercial turkesterone product in 24 young men and women for four weeks and measured body composition, handgrip strength, mood, and sleep quality. There were no significant differences in change scores between groups on any measure.

Four weeks is short, and both trials were small. A defender of turkesterone can fairly point out that neither study was powered to detect a small effect over a short window. That defense cuts both ways. If a compound needs a longer, larger, better-controlled study to show any signal at all, then whatever effect it has is small enough that it should not be priced at $50 a month or discussed in the same paragraph as anabolic steroids.

The Dissemond et al. (2025) trial deserves particular attention because it did something the others did not: it tested the product as well as the people. Twenty-eight resistance-trained men trained with free weights three times a week for 12 weeks while taking either a commercial phytosteroid product (20-hydroxyecdysone plus diosgenin) or placebo. Training produced significant strength and body composition improvements in both groups, with no group differences. The researchers then analyzed the supplement itself and found a large discrepancy between the claimed and actual concentrations of both active compounds, and confirmed the product produced no biological activity in C2C12 cells. In other words, the null result may not tell us much about ecdysteroids. It tells us a great deal about what people are buying.

The One Positive Study, Examined

Isenmann et al. (2019) is the load-bearing citation for the entire category, so it deserves a fair reading rather than dismissal.

The design was reasonable. Forty-six young men were assigned to groups over ten weeks of strength training, with placebo and ecdysterone arms at two dose levels. The results were substantial: the ecdysterone groups showed significantly greater increases in muscle mass, with the high-dose group gaining roughly 2 kg more than placebo, and bench press one-rep max improving by about 19.4 kg versus roughly 6.5 kg in the placebo group. No significant changes in testosterone or luteinizing hormone appeared, and liver and kidney markers stayed normal. The authors were confident enough in the size of the effect to recommend adding ecdysterone to the Prohibited List.

Now the asterisks, in order of severity.

The capsules did not contain what the label said

The research team analyzed the supplement they were administering. The capsules were labeled at 100 mg of ecdysterone each. Chemical analysis found they were underdosed by roughly 94%, containing somewhere around 6 mg apiece. The group nominally taking 800 mg per day was actually taking closer to 48 mg per day. This is a genuinely strange result to build a supplement industry on: the strongest evidence for ecdysterone comes from a study where the actual dose was under 6% of the marketed dose, and no follow-up trial has confirmed that a real 800 mg dose does anything at all. Every product on the market that cites this study to justify a high-milligram serving is citing it backwards.

The quantification method has known limitations

Plant extracts contain dozens of structurally similar ecdysteroids with overlapping ultraviolet absorbance. UV-based quantification cannot cleanly separate them, so it tends to overstate how much of any single target compound is present. This is a recognized issue in the analytical literature on ecdysteroids and a reason to treat single-lab dose figures in this field cautiously.

It has not been replicated

Seven years on, no independent group has reproduced the result. The trials that have run since, including one from an overlapping research group, came back null. In a field where a positive finding of this magnitude would be commercially and scientifically important, the absence of replication is information.

The Bioavailability Problem

Even if ecdysteroids do everything the cell studies suggest, there is a delivery problem that the marketing never addresses.

Pharmacokinetic work in rodents puts the oral bioavailability of 20-hydroxyecdysone at roughly 0.4% to 2%, averaging near 1.2%, with some variation between species and sexes. These molecules are polar, poorly absorbed, and heavily metabolized on first pass through the liver. Swallow 500 mg and single-digit milligrams may reach systemic circulation. There is even evidence that higher doses reduce fractional bioavailability further, possibly through saturation of gut uptake transporters or plain solubility limits, which would mean megadosing does not scale the way buyers assume.

Turkesterone's own bioavailability has essentially not been characterized in humans. The figures floating around product pages are extrapolations from 20E rodent work or, worse, invented.

The industry's answer to this is complexation with hydroxypropyl-beta-cyclodextrin (HPβCD), a ring-shaped sugar molecule that encapsulates poorly soluble compounds and can improve absorption. This is why so many turkesterone products list "10% turkesterone complexed with HPβCD" on the label. The chemistry is real and used legitimately in pharmaceuticals. But there is no published human pharmacokinetic study demonstrating how much a cyclodextrin complex raises turkesterone's oral bioavailability, and one practical consequence catches people out: HPβCD appears on the Department of Defense Prohibited Dietary Supplement Ingredients List. Service members who assume turkesterone is cleared because the ecdysteroid itself is not prohibited can still end up holding a prohibited product because of the delivery agent.

What Is Actually in the Bottle

Set the pharmacology aside for a moment. There is a more immediate problem: independent laboratory analyses of these products keep finding they do not contain what the label claims.

The most rigorous look came from Cohen et al. (2023) in JAMA Network Open, which analyzed 57 sports supplements containing five botanical ingredients with purported performance-enhancing properties, turkesterone among them. The findings were not marginal.

Read the Cohen numbers again. If you buy a botanical sports supplement in this category, the single most likely outcome is that it contains none of the active ingredient. The second most likely outcome is that it contains some amount wildly different from the label. Landing within 10% of the stated dose happened in about one product in nine.

There is a supply-chain reason for this. Genuine Ajuga turkestanica is a specific plant from a specific region, and it is expensive. Cyanotis arachnoidea is cheap, farmed at scale in China, and rich in ecdysterone but low in turkesterone. Todorova's team found exactly the fingerprint you would expect from substitution: products sold as turkesterone that contained more ecdysterone than turkesterone, which is the opposite of what an authentic A. turkestanica extract produces. The 2022 round of independent testing that circulated in the fitness community, in which multiple brands' turkesterone products came back looking nothing like Ajuga, was consistent with the same picture.

The 12% contamination figure from Cohen et al. deserves separate emphasis. Those products contained FDA-prohibited compounds not on the label, including synthetic stimulants such as deterenol, octodrine, oxilofrine, and 1,4-dimethylamylamine. For a tested athlete that is a failed drug test attached to a product you believed was a plant extract. For anyone else it is an undisclosed stimulant load.

Turkesterone vs Ecdysterone

Here is the part that gets lost in nearly every article on this topic. Almost all of the science belongs to ecdysterone. Almost all of the marketing belongs to turkesterone.

The pattern in that table is the story. The molecule with the thinner evidence base carries the heavier marketing, and it commands a premium price precisely because it is scarce enough to be worth counterfeiting. When a supplement's popularity is inversely correlated with the depth of its research, the popularity is being generated by something other than the research.

The one place ecdysterone has real institutional momentum is pharmaceutical development. A standardized formulation called BIO101 has gone through a Phase 1 safety and pharmacokinetics study (Dioh et al., 2023) and a Phase 2b trial in sarcopenic older adults at risk of mobility disability (Fielding et al., 2025), at 350 mg twice daily. That program is worth watching. It is also a different thing entirely from a bodybuilding supplement: a pharmaceutical-grade, dose-verified formulation, in an elderly clinical population, aimed at preserving function rather than adding muscle to a healthy trained lifter. Results there would not automatically transfer to a 25-year-old taking a capsule of unverified plant extract.

Safety and What Nobody Knows

The short-term human safety picture is unremarkable. Across the published trials, no serious adverse effects were reported. Isenmann et al. found no significant increases in liver or kidney toxicity markers and no significant change in testosterone or luteinizing hormone, though they did note variation in IGF-1 and some temporal effects on estradiol and thyroxine. Ecdysteroids do not appear to suppress endogenous testosterone, which is consistent with their not binding the androgen receptor.

That said, "no problems detected in six small short studies" is not the same as "safe." The honest inventory of what is unknown looks like this:

• No long-term human data. The longest supplement trial is 12 weeks. Nobody has run a year.
• No turkesterone-specific safety data. The US Department of Defense's Operation Supplement Safety states plainly that there is insufficient evidence to confirm the safety of turkesterone supplementation in humans.
• The ERβ question is open. If the mechanism runs through an estrogen receptor, the long-term consequences of chronically stimulating it in other tissues have not been studied.
• You do not know what you took. Given the label accuracy data, adverse events in this category are difficult to attribute. If someone reacts badly to a turkesterone product, the culprit could be the ecdysteroid, a substituted plant, a solvent residue, or an undeclared stimulant.

That last one is the practical safety issue. The risk in this category is less about the molecule and more about the supply chain.

Anti-Doping Status

For tested athletes, the current position is straightforward and worth stating precisely.

Ecdysterone has been on the WADA Monitoring Program since 2020. The Monitoring Program tracks substances that are not prohibited but that WADA wants usage data on. Being monitored carries no sanction. Ecdysterone remains off the 2026 Prohibited List despite the Isenmann authors' recommendation. Turkesterone is not on the Monitoring Program at all. Neither compound, nor their source plants, appears on the DoD Prohibited Dietary Supplement Ingredients List.

There is a structural reason WADA has been slow here that is rarely mentioned. Ecdysterone occurs naturally in spinach, quinoa, and asparagus. Prohibiting it outright would create a dietary minefield and force a threshold-based rule, similar to the way inhaled salbutamol is handled with a defined maximum. Setting a defensible threshold requires excretion and pharmacokinetic data that is still being assembled, which is part of what the Monitoring Program is for.

The Honest Verdict

Put the pieces together and the picture is clear enough to act on.

The mechanistic case is plausible and interesting. Cell studies show ecdysteroids can raise muscle protein synthesis, and the ERβ pathway is a legitimate target. The rodent literature is genuinely suggestive, if old and often conducted with injections. If a pharmaceutical program like BIO101 delivers, the class will have earned a place in the conversation.

The human supplement case is weak. Six controlled trials, one positive, and that one built on capsules containing about 6% of their labeled dose and never replicated. Both trials that tested turkesterone specifically found nothing. Oral bioavailability in the low single-digit percentages means the doses on the label were never the doses in your bloodstream anyway. And roughly 40% of products in this category contain no detectable amount of the ingredient you paid for.

Here is the sharpest framing. Suppose you take turkesterone for twelve weeks and gain muscle. What did that? You have a compound with no demonstrated human effect, at an unverified dose, from a product that statistically may contain none of it, while also training and eating. The signal-to-noise ratio makes personal verification impossible. That is exactly the environment where a supplement can sell for years on testimonials alone.

Compare that to what the same money buys elsewhere.

Creatine costs a fifth as much and has more supporting trials than turkesterone has total published human studies. That comparison is the whole argument.

If You Are Going to Try It Anyway

Some people will run the experiment regardless, and there are better and worse ways to do that. If you are going to spend the money, spend it in a way that at least produces information.

Buy only third-party tested product. Given a 40% chance of an empty capsule, this is not optional. Look for NSF Certified for Sport or Informed Sport certification, or at minimum a brand that publishes a batch-specific certificate of analysis from an accredited lab showing turkesterone quantified by HPLC. A "COA" that is a supplier document with no lab name and no batch number is decoration.

Know your actual milligrams. "500 mg Ajuga turkestanica extract" tells you nothing. "500 mg extract standardized to 10% turkesterone" tells you the dose is 50 mg. Products that hide behind a proprietary blend are disqualifying themselves.

Check for HPβCD if you are subject to DoD policy. The complexing agent, not the ecdysteroid, is what appears on the prohibited list.

Run it as an actual test. Give it 8 to 12 weeks, not four. Hold training and calories steady across the trial. Track objective numbers: body weight trend on a seven-day average, waist measurement, and top-set performance on two or three main lifts. Do not start it at the same time you change programs, start a bulk, or fix your sleep, because then you have learned nothing.

Do not stack it with other new supplements. One variable at a time, or the experiment is worthless.

Set a stop rule in advance. Decide before you start what result would make you keep buying it. If you cannot name that number, you were never running a test.

The Recurring Errors

Treating "no androgenic side effects" as proof of safety

Ecdysteroids not binding the androgen receptor explains why they do not cause acne or suppression. It is also the reason to doubt the anabolic claim, since the androgen receptor is the mechanism that makes anabolic steroids work. The absence of side effects is at least as consistent with the compound doing very little as with it being a clean anabolic.

Citing a study that recommends a ban as proof of potency

"Scientists want it banned" is persuasive marketing and weak evidence. WADA reviewed the same paper and declined to prohibit the substance across seven annual list cycles. The regulator with access to all the data reached a more cautious conclusion than the press release did.

Assuming a bigger label number means a bigger dose

Between 40% of products containing none of the ingredient and oral bioavailability in the low single digits, the number printed on the bottle has almost no relationship to what reaches your muscle. Paying more for 1,000 mg over 500 mg is paying for a number.

Confusing "understudied" with "promising"

These are opposite conditions. A compound with two null human trials has moved past "unproven" and started accumulating a negative record. Turkesterone has been tested more than most supplements marketed as cutting-edge, and it has not passed.

Buying the newest molecule in a class instead of the best-supported one

Supplement marketing consistently rewards novelty over evidence, because a new compound has no null studies attached to it yet. That is exactly why the industry moved from ecdysterone to turkesterone the moment ecdysterone's evidence base got complicated. Expect the next molecule in this class within a year or two, and expect it to be marketed the same way.

Frequently Asked Questions

Does turkesterone actually build muscle?

There is no good human evidence that it does. Antonio et al. (2024) gave 31 active adults 500 mg per day for four weeks and found no differences in body mass, lean mass, fat mass, or body fat percentage versus placebo. A 2025 trial in the Journal of the International Society of Sports Nutrition gave 24 participants a commercial turkesterone product for four weeks and found no differences in body composition, grip strength, mood, or sleep. The rodent studies behind the hype used injections, measured different endpoints, and do not translate to an oral capsule in a training human.

Is turkesterone a steroid?

It is a steroid chemically, in that it shares the four-ring steroid backbone, but it is not an anabolic-androgenic steroid. Ecdysteroids do not bind the androgen receptor, which is why they lack the suppression, acne, and hair loss associated with testosterone derivatives. It also means they do not work through the pathway that makes anabolic steroids effective. Cholesterol and vitamin D are steroids too. The shared shape tells you nothing about the effect.

What is the difference between turkesterone and ecdysterone?

Ecdysterone (20-hydroxyecdysone) is the most abundant and most researched phytoecdysteroid, found in Cyanotis, maral root, spinach, and quinoa. Turkesterone carries an extra hydroxyl group at the 11-alpha position and comes mainly from Ajuga turkestanica. Nearly all mechanistic and pharmacokinetic research has been done on ecdysterone. Turkesterone became the marketed molecule because it was rarer, more expensive, and had no null studies attached to its name at the time.

How much turkesterone should I take?

There is no established effective dose, because no dose has been shown to work in a controlled human trial. Most products supply 500 mg of extract standardized to 10% turkesterone, which is 50 mg of the actual compound. The 500 mg per day dose Antonio et al. (2024) tested produced no measurable effect. Anyone quoting a precise optimal dose is extrapolating from rodent data, not from human evidence.

Is turkesterone banned in sport?

No. Ecdysterone has been on the WADA Monitoring Program since 2020, meaning it is tracked but not prohibited, and it stays off the 2026 Prohibited List. Turkesterone is not even monitored. The larger risk for tested athletes is contamination: Cohen et al. (2023) found that 12% of the botanical sports supplements they analyzed contained at least one FDA-prohibited compound not declared on the label. Use only third-party certified products if you are tested.

Are turkesterone supplements safe?

Short-term trials have not reported serious adverse effects, and researchers have not found meaningful changes in liver or kidney markers or in testosterone. But nobody has run the studies needed to call it safe. There is no long-term human safety data on turkesterone as a supplement ingredient, and the Department of Defense's Operation Supplement Safety states there is insufficient evidence to confirm its safety in humans. Because label accuracy in this category is poor, the practical risk lies in what else is in the capsule.